WEST PALM BEACH, FL · ADULT MOOD-DISORDER PSYCHIATRY
Mood Disorder Treatment in West Palm Beach
Adult Mood Disorder Treatment Across the Full Spectrum
Mood disorder treatment at Mental Health West Palm Beach – Trustpsychiatry — DSM-5-TR · differential-diagnosis first · measurement-based med management, with meaningful improvement in 4–8 weeks and 3–12 months for long-term stabilization.
- ✓Full DSM-5-TR mood-spectrum scope
- ✓Differentiates unipolar vs bipolar (the 40% diagnostic-error frontier)
- ✓Augmentation, switch, and combination strategies
- ✓Combined med-mgmt + supportive psychotherapy in one chart
Serving West Palm Beach · Lake Worth · Wellington · Palm Beach · Greenacres · Riviera Beach · Statewide Florida telepsychiatry
WHAT TO EXPECT
What a mood-disorder intake actually looks like at Mental Health West Palm Beach – Trustpsychiatry.
Four anchors define the first visit and the months that follow. Mood disorders need longitudinal data — one interview rarely settles the unipolar-versus-bipolar question. The structure earns its keep.
| Anchor | Duration | Detail |
|---|---|---|
| Initial 60-min evaluation | 60 Min | DSM-5-TR mood-spectrum assessment with PHQ-9, MDQ bipolar screen, and collateral history from prior records or family when available. |
| Mood mapping | Longitudinal | Recurrent episodes, family history of bipolar, and longitudinal mood trajectory plotted across years — not just the last six months. |
| Med trial cadence per spectrum | SSRI vs stabilizer | SSRI/SNRI-first for unipolar; mood-stabilizer-first (lithium, lamotrigine, valproate) for bipolar spectrum per diagnostic frame. |
| Response & mood charting | PHQ-9 monthly | PHQ-9 administered each visit alongside patient-kept daily mood logs — the closest thing psychiatry has to a lab test for mood disorder. |
ACCESS & AVAILABILITY
✓Same-day when available · ✓Evening hours · ✓Weekend by appointment · ✓Statewide Florida telepsychiatry
Insurance benefits verified before your first visit at Mental Health West Palm Beach – Trustpsychiatry.
WHAT WE DELIVER
Adult mood-spectrum medication management — depression, bipolar, cyclothymia, PMDD.
Mood-disorder care here is built around six clinical anchors. DSM-5-TR drives the diagnosis; APA mood-disorder guidelines drive the prescribing logic. Medication and supportive psychotherapy work in the same chart so the plans talk to each other.
SSRIs/SNRIs for unipolar
Sertraline, escitalopram, fluoxetine, duloxetine, venlafaxine — first-line for major depressive disorder once a bipolar screen has cleared. Per STAR*D, adequate trial means therapeutic dose for 4–6 weeks before declaring response.
Mood stabilizers for bipolar spectrum
Lithium, valproate, and carbamazepine for bipolar I and II. Serum levels and thyroid panels are part of the work — not optional. Steady titration over weeks, not days.
Lamotrigine for BPII depression
First-line for the depressive pole of bipolar II per evidence-based guidelines. Slow titration is non-negotiable — the schedule exists to keep the rash risk low.
Atypicals for breakthrough
Quetiapine, lurasidone, and aripiprazole for mixed features, breakthrough episodes, and augmentation in treatment-resistant depression. Used surgically, never as a default.
PMDD treatment (luteal-phase SSRI)
Premenstrual dysphoric disorder responds to luteal-phase SSRI dosing strategies that continuous-dose regimens often miss. Tracked against a documented cycle log, not a guess.
Combined med-mgmt + supportive psychotherapy
Combined pharmacotherapy and psychoeducation outperforms either alone for mood disorders. Both managed in the same chart by the same prescriber — the plans talk to each other.
WHO WE SERVE
Adults whose mood story has more texture than a single SSRI prescription can capture.
Mood-disorder care here serves six recognizable presentations. Each one needs a different prescribing logic — and most have spent time on the wrong one.
| Archetype | Why mood-spectrum care fits |
|---|---|
| The recurrent depression adult | Multiple major depressive episodes across years — treatment cadence and continuation phase matter more than any single script. |
| The bipolar II adult misread as depression for years | Antidepressant after antidepressant, brief response, crash, repeat — the diagnostic frame needs to change before the prescription does. |
| The cyclothymic adult | Subthreshold mood swings cycling every few weeks for years — bipolar-spectrum prescribing logic, lower amplitudes. |
| The PMDD adult | Symptoms tracked to the luteal phase across at least two cycles — treated as PMDD, not as generic anxiety or depression. |
| The treatment-resistant mood patient | Two-plus failed antidepressant trials at adequate dose and duration — often a missed bipolar spectrum or under-treated unipolar. |
| Mood disorder with co-occurring anxiety, ADHD, or SUD | A single prescriber managing the mood plan and the co-occurring chart in concert — not in three separate offices. |
OUR PROCESS
How mood-disorder care unfolds at Mental Health West Palm Beach – Trustpsychiatry.
Three steps from first call to stable maintenance. Mood charting starts on day one and continues across the arc — measurement-based care is the spine of the work.
60-min eval with mood-spectrum screen
Lifetime mood history, MDQ bipolar screen, PHQ-9, prior medication response patterns, family history, hormonal and seasonal context, co-occurring screen. Mood charting starts on day one.
Differential diagnosis + treatment plan
Unipolar vs bipolar vs cyclothymia vs PMDD framed against the longitudinal data, not a single visit. SSRI/SNRI-first for unipolar, mood-stabilizer-first for bipolar spectrum, luteal-phase strategy for PMDD.
Ongoing measurement-based care + mood charting
PHQ-9 each visit, patient-kept daily mood logs, serum-level monitoring for lithium and lamotrigine when in play. Expect 4–8 weeks for meaningful improvement; 3–12 months for long-term stabilization.
WHAT THE EVIDENCE SAYS
Three things worth knowing about mood-disorder treatment.
DSM-5-TR criteria, APA mood-disorder guidelines, and the STAR*D paradigm converge on the same picture: differential diagnosis drives the treatment, sequenced trials beat first-line stubbornness, and combined pharmacotherapy plus supportive psychotherapy outperforms either alone.
“Roughly forty percent of adults presenting with depression who actually have bipolar II are misdiagnosed as unipolar — and the treatment for those two conditions diverges sharply at the prescription pad.”
Why the gap matters: SSRI monotherapy in unrecognized bipolar spectrum can lower the threshold for hypomanic switching and produce a chaotic course. Bipolar-screen-before-antidepressant is standard-of-care across the entire mood-disorder spectrum.
“STAR*D established the sequenced-treatment paradigm for major depression — adequate dose, adequate duration, then augment or switch. The pattern of failed trials is more diagnostically informative than any single result.”
Mechanism: STAR*D documented that one in three patients remit on first-line treatment, with cumulative remission rates climbing across sequenced trials. The implication is operational — treatment failure is not a verdict, it is a data point that refines the next step.
“Combined pharmacotherapy and psychoeducation outperforms either modality alone across the mood-disorder spectrum — the maintenance phase is where relapse gets prevented.”
Mechanism: medications stabilize neurochemistry; supportive psychotherapy teaches the pattern recognition that prevents the next episode. Holding both in the same chart, with the same prescriber, means the plans actually talk to each other instead of around each other.
Ready to put the evidence to work? Schedule a mood evaluation →
SCOPE — STRAIGHT
What we deliver — and what falls outside adult outpatient mood-disorder scope.
Mental Health West Palm Beach – Trustpsychiatry delivers adult outpatient mood-disorder care across the unipolar and bipolar spectrum, PMDD, and supportive psychotherapy combined with medication management. Pediatric care, inpatient management for severe mania or major depression with active safety risk, ECT, TMS, and rapid-cycling presentations requiring hospitalization all fall outside outpatient scope.
The flip side matters too — adult outpatient mood-disorder care here means a single prescriber managing the diagnosis, the medications, and the supportive psychotherapy in the same chart, with PHQ-9 and patient-kept mood logs anchoring the work. Leaving an intake without a new prescription is a valid outcome. The job is to match the case to the right level of care, not to write a script for its own sake.
Other Services at Mental Health West Palm Beach – Trustpsychiatry
More services at Mental Health West Palm Beach – Trustpsychiatry
Medication Management · Psychiatric Evaluation · Telepsychiatry Florida · Prescription Refills · MAT/Suboxone · Supportive Psychotherapy · TOVA Cognitive Testing
YOUR PRESCRIBER
Who you’ll see for adult mood-disorder care.
Josie Desmarais, PMHNP-BC, ANCC board-certified, sole prescriber at Mental Health West Palm Beach – Trustpsychiatry. 16+ years at Bay Pines VA Healthcare System (2007–2023) where the daily caseload ran heavy on recurrent depression, bipolar spectrum, and treatment-resistant mood — the exact territory this page covers. NPI 1255877932, FL APRN #1648222, FL E-FORCSE monitored prescribing.
Read Josie’s full bio →OUR LOCATION
Visit us in Haverhill, West Palm Beach.
Off I-95 at Belvedere Rd · 7 minutes from Palm Beach International Airport (PBI) · In Haverhill, West Palm Beach FL 33415
Adults across Lake Worth · Wellington · Palm Beach · Greenacres · Riviera Beach · statewide Florida via secure telepsychiatry.
Mental Health West Palm Beach – Trustpsychiatry
4500 Belvedere Rd, Suite D
West Palm Beach, FL 33415
Hours
Mon–Fri: 9:00 AM – 5:00 PM
Sat: By appointment
Sun: Closed
Related Conditions
Conditions we treat alongside mood disorders
Depression Treatment · Bipolar Disorder Treatment · Anxiety Treatment · ADHD Treatment · PTSD Treatment · OCD Treatment · Insomnia Treatment · Substance Use Disorder · CBT Therapy · DBT Therapy · ACT Therapy · Mindfulness Therapy
FREQUENTLY ASKED
Common questions about adult mood-disorder care.
What is a mood disorder? ▸
A category of DSM-5-TR conditions defined by sustained disturbance of mood. The umbrella covers major depressive disorder, persistent depressive disorder (dysthymia), bipolar I, bipolar II, cyclothymia, premenstrual dysphoric disorder, and seasonal patterns. The label matters less than the differential — treatment diverges meaningfully across the spectrum.
How do you tell unipolar from bipolar? ▸
Longitudinal data, family history, and antidepressant response patterns. Brief stretches of unusually high energy, reduced sleep need, racing thoughts, or irritability — especially if they followed an SSRI trial — point toward bipolar spectrum even when the visit captures only the depressive pole. MDQ screening and daily mood logs across two to three months refine the call.
What is PMDD? ▸
Premenstrual dysphoric disorder — a mood disorder with symptoms reliably anchored to the luteal phase of the menstrual cycle, documented across at least two cycles. PMDD responds to luteal-phase SSRI dosing strategies that continuous-dose regimens often miss. The treatment plan depends on a documented cycle log, not a guess.
How long until medications work? ▸
Expect 4–8 weeks for meaningful improvement and 3–12 months for long-term stabilization. SSRIs and SNRIs typically show response across 4–6 weeks at therapeutic dose per STAR*D doctrine. Lithium and lamotrigine work through slower, dose-dependent stabilization — steady titration is part of the work, not optional. Bipolar maintenance often runs long-term.
What if I have multiple diagnoses? ▸
Mood disorders often co-travel with anxiety, ADHD, SUD, insomnia, and PTSD. At a single-condition clinic those usually route to a separate prescriber whose plan does not talk to the mood plan. Here, all of it lives in the same chart with the same prescriber adjusting them in concert — medication interactions, sequencing, and response checks all sit in one place.
Can I do telepsych? ▸
Yes. Mood-disorder follow-ups are eligible for telepsychiatry across all 67 Florida counties. Initial 60-minute evaluations can be conducted in-office or by secure video — the intake confirms the format that fits the case. Lithium and lamotrigine serum monitoring is coordinated with local labs near you.
What about side effects? ▸
Side effects are reviewed at every visit, not just at start. SSRIs and SNRIs commonly cause transient GI symptoms, sleep changes, or sexual side effects across the first weeks. Lithium requires serum monitoring and thyroid panels. Lamotrigine has a strict slow-titration schedule to keep rash risk low. The FDA boxed warning for antidepressants under 25 governs close suicidality monitoring during initiation and dose changes.
Will I be on medication forever? ▸
It depends on the diagnosis. Single-episode major depression often allows a tapered discontinuation 6–12 months after sustained remission. Recurrent depression typically warrants longer maintenance. Bipolar I and II maintenance is often long-term — discontinuation is associated with high relapse rates and is decided with the prescriber, never abruptly. The plan is revisited at every visit, never set in stone.
READY WHEN YOU ARE
Start with the mood evaluation.
In-network with twelve major Florida plans. 60-minute DSM-5-TR mood-spectrum evaluation, differential diagnosis before the prescription, mood charting from day one, supportive psychotherapy combined with med management in the same chart.
Crisis support: 988 Suicide & Crisis Lifeline. For medical emergency, call 911.